*By Samantha Errico* Your days to travel in 2018 may be numbered, but 2019 beckons. So what's ahead for the travel industry next year? Lola.com CEO Mike Volpe joined Cheddar to present his predictions for travel in 2019. **Day-Rate Hotels** "In this world where everyone wants to be faster and more agile, your needs around business are changing," Volpe told Cheddar Friday. Hotels are incorporating flexible check-in times for travelers who take red eyes, and offering hourly rates for visitors who are only in town for the day. Hotels are adapting to the pace of the modern travel and the growing demand of customers. **Out with Corporate Travel, in with Consumer Travel** The business travel industry is expected to hit $1.6 trillion by 2020, and more companies are trying to exploit the market. Companies are meeting the growing demands of the market by "taking the consumer speed and agility from the consumer travel world into the corporate travel world," Volpe said. Travel companies are racing to find the easiest booking system possible, Volpe said. "The average corporate travel system takes a person about an hour to book their flight and hotel for an upcoming trip," he added.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More